Filing Details

Accession Number:
0001209191-22-046250
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 16:19:11
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 16:19:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1868734 Cincor Pharma Inc. CINC () I0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574139 Sas Partners Sofinnova 7-11 Boulevard Haussmann
Paris I0 75009
No No Yes No
1849915 Ix Capital Sofinnova 7-11 Boulevard Haussmann
Paris I0 75009
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-15 133,333 $30.00 4,220,979 No 4 P Indirect By Sofinnova Capital IX
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sofinnova Capital IX
Footnotes
  1. The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may bedeemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to theextent of its pecuniary interest therein.